Abbott Told To Pay J&J $1.67 Billion Over Patent - WSJ.com

Abbott Told To Pay J&J $1.67 Billion Over Patent - WSJ.com: "A federal jury in Texas Monday upheld the patent on Johnson & Johnson's arthritis treatment Remicade and ordered Abbott Laboratories to pay its rival $1.67 billion for infringing on the patent."